Results 1 - 10 of 66

< 1 2 3 ... 6 7 >

• Protease Inhibitor Resistance, Handbook of Antimicrobial Resistance

  [DOI: 10.1007/978-1-4939-0694-9_6]
  
• Treatment Effects and Resistance-Associated Variants of Sofosbuvir Regimen for Japanese Patients with Chronic Hepatitis C Virus Genotypes 1 and 2, Hepatitis C Virus Treatment

  [DOI: 10.1007/978-981-10-2416-0_7]
  
• The Efficacy of Daclatasvir Plus Asunaprevir Combination Therapy with Chronic Hepatitis, Hepatitis C Virus Treatment

  [DOI: 10.1007/978-981-10-2416-0_3]
  
• Resistance-Associated Variants in the NS5A Region of HCV and Methods for the Detection, Hepatitis C Virus Treatment

  [DOI: 10.1007/978-981-10-2416-0_4]
  
• Features of the Second Wave of the First Generation Protease Inhibitors: Effect and Tolerance, Hepatitis C Virus Treatment

  [DOI: 10.1007/978-981-10-2416-0_2]
  
• Emerging Antivirals in the Future, Hepatitis C Virus Treatment

  [DOI: 10.1007/978-981-10-2416-0_8]
  
• Detection of Antiviral Drug-Resistant Variants in Chronic Hepatitis C by Deep Sequencing, Hepatitis C Virus Treatment

  [DOI: 10.1007/978-981-10-2416-0_5]
  
• A Review of Daclatasvir Drugu2013Drug Interactions, Advances in Therapy

  [DOI: 10.1007/s12325-016-0407-5]
  
• Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection, Journal of Gastroenterology

  [DOI: 10.1007/s00535-018-1445-3]
  
• Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection, Journal of Gastroenterology

  [DOI: 10.1007/s00535-016-1245-6]